We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
11 hedge funds and large institutions have $15.3M invested in ESSA Pharma in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
924% more capital invested
Capital invested by funds: $1.49M → $15.3M (+$13.8M)
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
10% more funds holding
Funds holding: 10 → 11 (+1)
2.12% more ownership
Funds ownership: 1.19% → 3.31% (+2.1%)
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.25%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
3
Increased
5
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CV
Clarus Ventures
Cambridge,
Massachusetts
|
+$6.51M |
| 2 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$4.17M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$2.12M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$1.44M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.9K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$121 |